Amplifon S.p.A. (BIT:AMP)
Italy · Delayed Price · Currency is EUR | Market Cap | 2.45B -35.6% |
| Revenue (ttm) | 2.39B -1.5% |
| Net Income | 68.93M -51.9% |
| EPS | 0.31 -51.6% |
| Shares Out | 219.97M |
| PE Ratio | 36.38 |
| Forward PE | 14.80 |
| Dividend | 0.29 (2.59%) |
| Ex-Dividend Date | May 18, 2026 |
| Volume | 2,599,075 |
| Average Volume | 2,716,072 |
| Open | 11.32 |
| Previous Close | 11.22 |
| Day's Range | 11.00 - 11.35 |
| 52-Week Range | 7.84 - 21.40 |
| Beta | 0.94 |
| RSI | 69.42 |
| Earnings Date | May 5, 2026 |
About Amplifon
Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. [Read more]
Financial Performance
In 2025, Amplifon's revenue was 2.40 billion, a decrease of -0.56% compared to the previous year's 2.41 billion. Earnings were 91.33 million, a decrease of -37.17%.
Financial StatementsNews
Q1 2026 Amplifon SpA Earnings Call Transcript
Q1 2026 Amplifon SpA Earnings Call Transcript
Amplifon Q1 Profit Falls
(RTTNews) - Italy-based hearing aid retailer Amplifon S.p.A. (AMP.MI, AMFPF) on Tuesday reported lower first-quarter net profit, hurt largely by one-off charges related to divestitures, which offset s...
Amplifon Earnings Call Transcript: Q1 2026
Strong Q1 2026 results with record profitability and accelerating organic growth, driven by momentum in key markets and effective execution of strategic initiatives. Confident outlook for 2026 with organic growth above 3% and further margin expansion expected.
What To Expect From Amplifon SpA (MIL:AMP) Q1 2026 Earnings
What To Expect From Amplifon SpA (MIL:AMP) Q1 2026 Earnings
EssilorLuxottica's Strategic Focus on Audio Devices Amid Amplifon Investment Talks
EssilorLuxottica's Strategic Focus on Audio Devices Amid Amplifon Investment Talks
EssilorLuxottica considered investing in Amplifon in the past, CEO says
Franco-Italian eyewear giant EssilorLuxottica looked at investing in Italian hearing aid maker Amplifon in the past, CEO Francesco Milleri said on Tuesday.
Amplifon Transcript: M&A announcement
A transformative acquisition will create a global, vertically integrated leader in hearing care, combining advanced technology and clinical expertise. The deal, valued at EUR 2.3 billion, targets EUR 60–80 million in synergies by 2029 and is expected to close by end-2026, pending regulatory approvals.
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
Today, GN Store Nord A/S (“GN”) has entered into a definitive agreement for the sale of GN's Hearing business to Amplifon S.p.A. (“Amplifon”), a leading global hearing care retailer. The transaction v...
Amplifon Earnings Call Transcript: Q4 2025
2025 saw modest revenue growth and margin pressure amid weak market demand, but efficiency initiatives and portfolio optimization are driving improved profitability. The Fit4Growth plan is ahead of schedule, with significant margin gains expected by 2027.
SHORT TAKE Amplifon posts Q3 profit fall, confirms 2025 guidance
Italian hearing aid group Amplifon reported a 27.7% drop in its third-quarter adjusted net profit to 19.2 million euros ($22.4 million) on Wednesday.
Amplifon Earnings Call Transcript: Q3 2025
Q3 saw 2.4% sales growth at constant FX and a 19.1% adjusted EBITDA margin, with strong U.S. and EMEA performance offset by FX headwinds and APAC weakness. The Fit for Growth program is ahead of schedule, targeting improved margins by 2027, and full-year revenue growth is guided at 2–2.5%.
Amplifon Earnings Call Transcript: Q2 2025
Q2 and H1 2025 saw modest revenue growth but declining margins amid macroeconomic headwinds, with EMEA and Southern Europe particularly weak. The 'Fit for Growth' program aims to structurally boost profitability, and guidance anticipates improved conditions and 3% revenue growth for FY25.
Amplifon Earnings Call Transcript: Q1 2025
Revenues grew 2.6% year-over-year, with record adjusted EBITDA margin and strong M&A activity. Outlook for 2025 is confirmed, expecting acceleration in revenue growth, especially in France and the U.S., supported by new product launches and favorable market trends.
Amplifon Earnings Call Transcript: Q4 2024
Revenue grew 7% at constant FX in 2024, led by strong U.S. gains and muted Europe, with significant investments in capacity and marketing. 2025 guidance targets 5–9% revenue growth and margin expansion above 24%, driven by a European recovery, especially in France, and continued U.S. growth.
Italy's Amplifon posts 2024 margin below guidance, shares drop 12%
Italian hearing aid company Amplifon reported an annual core profit margin of 23.6% on Thursday, short of its revised guidance of 24%, which along with a drop in net profit sent its shares falling 12%...
Amplifon Hearing Health Care Achieves HITRUST r2 Certification
MINNEAPOLIS--(BUSINESS WIRE)--Amplifon Hearing Health Care, the leading independent provider of hearing benefit solutions in the U.S., has earned certified status by HITRUST for information security f...
Amplifon Earnings Call Transcript: Q3 2024
Q3 saw 8% revenue growth at constant FX, driven by strong organic and M&A expansion, despite a flat European market and margin pressure from investments and network transformation. Outlook remains positive for 2025, especially in France, with continued focus on growth and profitability.
Italy's Amplifon trims margin forecast after lower Q3 profit
Italian hearing aid company Amplifon slightly lowered its annual margin guidance on Wednesday, after it posted a drop in third-quarter net profit due to increased financial expenses and higher depreci...
Amplifon Named One of the 200 “America's Most Loved Workplaces” by Newsweek
MINNEAPOLIS--(BUSINESS WIRE)--Amplifon, parent company of Miracle-Ear and the world leader in hearing care services and solutions, has been included in Newsweek's annual ranking of America's 200 Most ...
Amplifon Earnings Call Transcript: Q2 2024
Q2 and H1 2024 saw strong revenue and EBITDA growth, driven by robust U.S. and Asia Pacific performance and significant M&A, despite European market volatility and margin dilution from direct retail expansion. Guidance for high single-digit sales growth and margin improvement is maintained.
Amplifon, Parent Company of Miracle-Ear, Listed Among the “World's Most Sustainable Companies” in 2024 by Statista and TIME Magazine
MINNEAPOLIS--(BUSINESS WIRE)--Amplifon, parent company of Miracle-Ear and a world leader in hearing care services and solutions, has been included among the World's Most Sustainable Companies 2024 for...
Amplifon Earnings Call Transcript: Q1 2024
Amplifon Earnings Call Transcript: Q4 2023
Amplifon Recognized as 2024 Top Employer for the First Time in North America and Canada
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Amplifon, the world leader in hearing care services and solutions, has been confirmed as a global ‘Top Employer' and received the award for the first time for th...
Amplifon and Miracle-Ear Recognized as 2024 Top Employers in the U.S. and, for the First Time, in North America
MINNEAPOLIS--(BUSINESS WIRE)--Amplifon, the world leader in hearing care services and solutions, and its subsidiaries, Miracle-Ear and Amplifon Hearing Health Care, have been confirmed as global ‘Top ...